Diametric Capital’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-12,186
| Closed | -$210K | – | 318 |
|
|
2022
Q3 | $210K | Buy |
12,186
+9
| +0.1% | +$155 | 0.11% | 216 |
|
|
2022
Q2 | $134K | Buy |
12,177
+3,030
| +33% | +$33.3K | 0.1% | 219 |
|
|
2022
Q1 | $203K | Buy |
9,147
+4,123
| +82% | +$91.5K | 0.11% | 186 |
|
|
2021
Q4 | $173K | Buy |
5,024
+1,533
| +44% | +$52.8K | 0.13% | 139 |
|
|
2021
Q3 | $214K | Sell |
3,491
-526
| -13% | -$32.2K | 0.17% | 112 |
|
|
2021
Q2 | $313K | Buy |
+4,017
| New | +$313K | 0.23% | 97 |
|